Bellerophon Therapeutics Inc expected to post a loss of 55  cents a share - Earnings Preview

Bellerophon Therapeutics

06/05/2022 19:34

* Bellerophon Therapeutics Inc  BLPH.OQ   BLPH.O  is
expected
to show no change in quarterly revenue when it reports 
results on May 9 (estimated). 
    * ​Refinitiv's mean analyst estimate for Bellerophon
Therapeutics
Inc is for a loss of 55 cents per share. For the same quarter
last year, the company reported a loss of 58 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 6.3%
in the last three months. ​
    * Wall Street's median 12-month price target for Bellerophon
Therapeutics Inc is $24.5​, above​ its last closing price
of $1.30. ​​​

This summary was machine generated May 6 at 18:34 GMT.  All
figures in US dollars  unless otherwise stated